Skip to main content
Mijn bibliotheek
Shop
Nieuws Boeken Tijdschriften Toetsvragen Web-tv Video Audio
Tips voor Mijn BSL
Inloggen
Top
Quality of Life Research
Gepubliceerd in:

01-12-2014

Factors associated with quality of life measured by EQ-5D in patients with nontuberculous mycobacterial pulmonary disease

Auteurs: Ji Young Hong, Sang A. Lee, Song Yee Kim, Kyung Soo Chung, Sung Woo Moon, Eun Young Kim, Ji Ye Jung, Moo Suk Park, Young Sam Kim, Se Kyu Kim, Joon Chang, Young Ae Kang

Gepubliceerd in: Quality of Life Research | Uitgave 10/2014

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail
    Link delen
publish
Publiceer nu

Abstract

Purpose

The impact of pulmonary nontuberculous mycobacterial (pNTM) disease on health-related quality of life (HRQoL) has not received significant attention in the literature. In this study, we compared the HRQoL in patients with pNTM disease and healthy subjects and identified influencing factors using EuroQol 5D (EQ-5D) data.

Methods

The present study used an age- and sex-matched case–control analysis from a cohort of 85 pNTM patients and 340 participants from a national survey. Baseline EQ-5D utility scores and EQ-5D visual analog scale (VAS) scores were measured in both groups. In patients with pNTM disease, the factors affecting EQ-5D were identified using multiple linear regression analysis.

Results

While the median EQ-5D VAS scores were lower in pNTM patients than in the control subjects (pNTM, 70; control, 80; P < 0.001), the median EQ-5D utility scores were similar in two groups (both, 1.000, P = 0.878). Interestingly, the percentage of subjects reporting problems on the anxiety/depression dimension was higher for patients with pNTM disease (18.8 %) compared with the control subjects (11.5 %, P = 0.07). In multivariate analysis, increasing severity of forced expired volume in one second (FEV1) decline was associated with a significant decrease in EQ-5D scores of pNTM patients.

Conclusions

This study suggested the EQ-5D may not be useful instrument in pNTM patients due to ceiling effect of EQ-5D and mild disease activity. Patients with pNTM disease tended to report more reduced health status and more problems with anxiety/depression than the healthy controls. Lung function, measured by FEV1, was independently associated with EQ-5D scores in patients with pNTM disease.
vorige artikel The health-related quality of life of Chinese patients with lower urinary tract symptoms in primary care
volgende artikel Effect of perioperative complications and functional outcomes on health-related quality of life after radical prostatectomy
Literatuur
1.
Prevots, D. R., Shaw, P. A., Strickland, D., Jackson, L. A., Raebel, M. A., Blosky, M. A., et al. (2010). Nontuberculous mycobacterial lung disease prevalence at four integrated health care delivery systems. American Journal of Respiratory and Critical Care Medicine, 182(7), 970–976.PubMedCentralPubMedCrossRef
2.
Winthrop, K. L., McNelley, E., Kendall, B., Marshall-Olson, A., Morris, C., Cassidy, M., et al. (2010). Pulmonary nontuberculous mycobacterial disease prevalence and clinical features: An emerging public health disease. American Journal of Respiratory and Critical Care Medicine, 182(7), 977–982.PubMedCrossRef
3.
Griffith, D. E., Aksamit, T., Brown-Elliott, B. A., Catanzaro, A., Daley, C., Gordin, F., et al. (2007). An official ATS/IDSA statement: Diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. American Journal of Respiratory and Critical Care Medicine, 175(4), 367–416.PubMedCrossRef
4.
Huang, J. H., Kao, P. N., Adi, V., & Ruoss, S. J. (1999). Mycobacterium avium-intracellulare pulmonary infection in HIV-negative patients without preexisting lung disease: Diagnostic and management limitations. Chest, 115(4), 1033–1040.PubMedCrossRef
5.
Guyatt, G. H., Feeny, D. H., & Patrick, D. L. (1993). Measuring health-related quality of life. Annals of Internal Medicine, 118(8), 622–629.PubMedCrossRef
6.
Voll-Aanerud, M., Eagan, T. M., Wentzel-Larsen, T., Gulsvik, A., & Bakke, P. S. (2008). Respiratory symptoms, COPD severity, and health related quality of life in a general population sample. Respiratory Medicine, 102(3), 399–406.PubMedCrossRef
7.
Mehta, M., & Marras, T. K. (2011). Impaired health-related quality of life in pulmonary nontuberculous mycobacterial disease. Respiratory Medicine, 105(11), 1718–1725.PubMedCrossRef
8.
Glasziou, P., Alexander, J., Beller, E., & Clarke, P. (2007). Which health-related quality of life score? A comparison of alternative utility measures in patients with type 2 diabetes in the ADVANCE trial. Health Qual Life Outcomes, 5, 21.PubMedCentralPubMedCrossRef
9.
Sullivan, P. W., Lawrence, W. F., & Ghushchyan, V. (2005). A national catalog of preference-based scores for chronic conditions in the United States. Medical Care, 43(7), 736–749.PubMedCrossRef
10.
Sim, Y. S., Park, H. Y., Jeon, K., Suh, G. Y., Kwon, O. J., & Koh, W. J. (2010). Standardized combination antibiotic treatment of Mycobacterium avium complex lung disease. Yonsei Medical Journal, 51(6), 888–894.PubMedCentralPubMedCrossRef
11.
Lee, H., Park, H. J., Cho, S. N., Bai, G. H., & Kim, S. J. (2000). Species identification of mycobacteria by PCR-restriction fragment length polymorphism of the rpoB gene. Journal of Clinical Microbiology, 38(8), 2966–2971.PubMedCentralPubMed
12.
Chung, M. J., Lee, K. S., Koh, W. J., Lee, J. H., Kim, T. S., Kwon, O. J., et al. (2005). Thin-section CT findings of nontuberculous mycobacterial pulmonary diseases: Comparison between Mycobacterium avium-intracellular complex and Mycobacterium abscessus infection. Journal of Korean Medical Science, 20(5), 777–783.PubMedCentralPubMedCrossRef
13.
Kitada, S., Kobayashi, K., Ichiyama, S., Takakura, S., Sakatani, M., Suzuki, K., et al. (2008). Serodiagnosis of Mycobacterium avium-complex pulmonary disease using an enzyme immunoassay kit. American Journal of Respiratory and Critical Care Medicine, 177(7), 793–797.PubMedCrossRef
14.
15.
Rabin, R., & de Charro, F. (2001). EQ-5D: A measure of health status from the EuroQol group. Annals of Medicine, 33(5), 337–343.PubMedCrossRef
16.
EuroQol group. (1990). EuroQol: A new facility for the measurement of health-related quality of life. Health Policy, 16(3), 199–208.CrossRef
17.
Rutten-van Molken, M. P., Oostenbrink, J. B., Tashkin, D. P., Burkhart, D., & Monz, B. U. (2006). Does quality of life of COPD patients as measured by the generic EuroQol five-dimension questionnaire differentiate between COPD severity stages? Chest, 130(4), 1117–1128.PubMedCrossRef
18.
Lee, Y. K., Nam, H. S., Chuang, L. H., Kim, K. Y., Yang, H. K., Kwon, I. S., et al. (2009). South Korean time trade-off values for EQ-5D health states: Modeling with observed values for 101 health states. Value Health, 12(8), 1187–1193.PubMedCrossRef
19.
van Manen, J. G., Bindels, P. J., Dekker, F. W., Bottema, B. J., van der Zee, J. S., Ijzermans, C. J., et al. (2003). The influence of COPD on health-related quality of life independent of the influence of comorbidity. Journal of Clinical Epidemiology, 56(12), 1177–1184.PubMedCrossRef
20.
Hayashi, M., Takayanagi, N., Kanauchi, T., Miyahara, Y., Yanagisawa, T., & Sugita, Y. (2012). Prognostic factors of 634 HIV-negative patients with Mycobacterium avium complex lung disease. American Journal of Respiratory and Critical Care Medicine, 185(5), 575–583.PubMedCrossRef
21.
Khan, Z., Miller, A., Bachan, M., & Donath, J. (2010). Mycobacterium avium complex (MAC) lung disease in two inner city community hospitals: Recognition, prevalence, co-infection with Mycobacterium tuberculosis (MTB) and pulmonary function (PF) improvements after treatment. The Open Respiratory Medicine Journal, 4, 76–81.PubMedCentralPubMedCrossRef
22.
Lee, M. R., Yang, C. Y., Chang, K. P., Keng, L. T., Yen, D. H., Wang, J. Y., et al. (2013). Factors associated with lung function decline in patients with non-tuberculous mycobacterial pulmonary disease. PLoS One, 8(3), e58214.PubMedCentralPubMedCrossRef
23.
Oh, E. G., Bang, S. Y., Kim, Y. S., Park, M. S., & Kim, S. K. (2009). Health-related quality of life among Koreans with chronic respiratory disease. The International Journal of Tuberculosis and Lung Disease, 13(5), 580–586.PubMed
24.
Pickard, A. S., Wilke, C., Jung, E., Patel, S., Stavem, K., & Lee, T. A. (2008). Use of a preference-based measure of health (EQ-5D) in COPD and asthma. Respiratory Medicine, 102(4), 519–536.PubMedCrossRef
25.
Cook, J. L. (2010). Nontuberculous mycobacteria: Opportunistic environmental pathogens for predisposed hosts. British Medical Bulletin, 96, 45–59.PubMedCrossRef
26.
Puhan, M. A., Guyatt, G. H., Goldstein, R., Mador, J., McKim, D., Stahl, E., et al. (2007). Relative responsiveness of the Chronic Respiratory Questionnaire, St. Georges Respiratory Questionnaire and four other health-related quality of life instruments for patients with chronic lung disease. Respiratory Medicine, 101(2), 308–316.PubMedCrossRef
27.
Brazier, J., Roberts, J., Tsuchiya, A., & Busschbach, J. (2004). A comparison of the EQ-5D and SF-6D across seven patient groups. Health Economics, 13(9), 873–884.PubMedCrossRef
28.
Harper, R., Brazier, J. E., Waterhouse, J. C., Walters, S. J., Jones, N. M., & Howard, P. (1997). Comparison of outcome measures for patients with chronic obstructive pulmonary disease (COPD) in an outpatient setting. Thorax, 52(10), 879–887.PubMedCentralPubMedCrossRef
29.
Szende, A., Leidy, N. K., Stahl, E., & Svensson, K. (2009). Estimating health utilities in patients with asthma and COPD: Evidence on the performance of EQ-5D and SF-6D. Quality of Life Research, 18(2), 267–272.PubMedCrossRef
30.
Huang, C. T., Tsai, Y. J., Wu, H. D., Wang, J. Y., Yu, C. J., Lee, L. N., et al. (2012). Impact of non-tuberculous mycobacteria on pulmonary function decline in chronic obstructive pulmonary disease. The International Journal of Tuberculosis and Lung Disease, 16(4), 539–545.PubMedCrossRef
31.
Antonelli-Incalzi, R., Imperiale, C., Bellia, V., Catalano, F., Scichilone, N., Pistelli, R., et al. (2003). Do GOLD stages of COPD severity really correspond to differences in health status? European Respiratory Journal, 22(3), 444–449.PubMedCrossRef
Metagegevens
Titel
Factors associated with quality of life measured by EQ-5D in patients with nontuberculous mycobacterial pulmonary disease
Auteurs
Ji Young Hong
Sang A. Lee
Song Yee Kim
Kyung Soo Chung
Sung Woo Moon
Eun Young Kim
Ji Ye Jung
Moo Suk Park
Young Sam Kim
Se Kyu Kim
Joon Chang
Young Ae Kang
Publicatiedatum
01-12-2014
Uitgeverij
Springer International Publishing
Gepubliceerd in
Quality of Life Research / Uitgave 10/2014
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-014-0727-3

Andere artikelen Uitgave 10/2014

Emotional vitality in family caregivers: content validation of a theoretical framework

The relationships between demographic and clinical characteristics and quality of life during and after radiotherapy: in women with breast cancer

Setting standards for severity of common symptoms in oncology using the PROMIS item banks and expert judgment

Reliability and validity of a survey to measure bowel function and quality of life in long-term rectal cancer survivors

Health status profiles in community-dwelling elderly using self-reported health indicators: a latent class analysis

Physical activity and health-related quality of life: US adults with and without limitations